Japan sales expected to exceed 2025 despite Q2 decline
Aflac's Q2 2026 call revealed a solid quarter with adjusted EPS of $1.75, but the overall tone was neutral. The main strategic headlines were a significant $4.8 billion portfolio repositioning to boost investment income and a substantial expansion of the internal reinsurance target for Japan, signaling a more active capital management strategy. Guidance for US premium growth was slightly lowered. Adjusted EPS of $1.75 in Q2, up 1.1% year-over-year, with ROE at 12.7% (16.6% ex-FX).
Buzzberg readJapan sales expected to exceed 2025 despite Q2 declineAflac's Q2 2026 call revealed a solid quarter with adjusted EPS of $1.75, but the overall tone was neutral. The main strategic headlines were a significant $4.8 billion portfolio repositioning to boost investment income and a substantial expansion of the internal reinsurance target for Japan, signaling a more active capital management strategy. Guidance for US premium growth was slightly lowered. Adjusted EPS of $1.75 in Q2, up 1.1% year-over-year, with ROE at 12.7% (16.6% ex-FX).Read full analysisCollapse analysis
Aflac's Q2 2026 call revealed a solid quarter with adjusted EPS of $1.75, but the overall tone was neutral. The main strategic headlines were a significant $4.8 billion portfolio repositioning to boost investment income and a substantial expansion of the internal reinsurance target for Japan, signaling a more active capital management strategy. Guidance for US premium growth was slightly lowered. Adjusted EPS of $1.75 in Q2, up 1.1% year-over-year, with ROE at 12.7% (16.6% ex-FX).
Japan sales declined -5.6% in the quarter but remain up 7% for the first half; management still expects full-year sales to exceed 2025.
Aflac repositioned $4.8 billion in investments via switch trades, expecting to boost net investment income by over $50 million annually.
The internal reinsurance target for Japan was raised from 10% of US GAAP assets to 30% of FSA reserves, signaling a potential multi-billion dollar capital source.
JAPAN revenue$11B
reported
Revenue$4.083B
-5% QoQ
EPS$1.75
+0% QoQ
Gross margin54.64%
reported
What changed this quarter
01
Guidance
Japan sales expected to exceed 2025 despite Q2 decline
Guidance tone
02
Demand
US sales up 2.6% with group momentum
Management highlighted strong sales momentum in Japan, particularly for the new Sumitas and Anshin Pallet products, and expects full-year Japan sales to exceed 2025. In the U.S., sales increased 2.6% year-over-year with particular strength in group voluntary and dental/vision…
03
Capital Management
Japan reinsurance limit raised to 30% of FSA reserves
Japan sales declined -5.6% in the quarter but remain up 7% for the first half; management still expects full-year sales to exceed 2025.
04
Investments
Asset repositioning to add $50 million annual NII
Aflac repositioned $4.8 billion in investments via switch trades, expecting to boost net investment income by over $50 million annually.
Demand
Demand
Bookings & conversion
Management highlighted strong sales momentum in Japan, particularly for the new Sumitas and Anshin Pallet products, and expects full-year Japan sales to exceed 2025. In the U.S., sales increased 2.6% year-over-year with particular strength in group voluntary and dental/vision products, and management expects a stronger second half with growth higher than last year.
Tone · Measured
Management expressed confidence in the business and strategic initiatives, but also acknowledged headwinds such as elevated benefit ratios and a competitive sales environment.
Supply-chain alpha
A1
Aflac repositioned $4.8 billion of its investment portfolio in a single quarter, capturing foreign currency gains to minimize losses on lower-yielding assets and boost net investment income by over $50 million annually.
“During the quarter, our global investments team were quite active repositioning $4.8 billion of their portfolio through switch trades to capture the benefit of higher yields and further strengthen the overall quality of our consolidated po…”
Aflac has internally raised its reinsurance target for Japan from 10% of US GAAP assets to 30% of FSA reserves, potentially freeing up billions in capital for future deployment.
“We have revisited this target and aligned it with an FSA perspective of up to 30% of FSA reserves. This will allow us to continue to reduce risk, improve balance sheet efficiency, and ultimately generate a higher ROE for Affleck Japan and…”